{
    "title": "Eli Lilly defeats Teva appeal over Alimta cancer drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4114202/Eli-Lilly-defeats-Teva-appeal-Alimta-cancer-drug.html",
    "date": "2017-01-12",
    "keywords": [
        "patent",
        "drug",
        "court",
        "cancer",
        "alimta",
        "percent",
        "gmt",
        "jonathan",
        "stempel",
        "bill",
        "circuit",
        "judge",
        "right",
        "loss",
        "appeal",
        "email",
        "thursday",
        "co",
        "equivalent",
        "lung",
        "let",
        "teva",
        "infringement",
        "threejudge",
        "panel",
        "chief",
        "sharon",
        "prost",
        "evidence",
        "tevas",
        "product",
        "generic",
        "intent",
        "spokeswoman",
        "denise",
        "bradley",
        "drugmaker",
        "decision",
        "district",
        "walton",
        "pratt",
        "indianapolisalimta",
        "chemical",
        "name",
        "accounting",
        "revenuethe",
        "question",
        "method",
        "acid",
        "vitamin",
        "b12",
        "toxicity",
        "ability",
        "harrington",
        "counsel",
        "statement",
        "company",
        "jan",
        "analyst",
        "tim",
        "anderson",
        "research",
        "note",
        "protection",
        "midday",
        "trading",
        "case",
        "v",
        "reporting",
        "berkrot",
        "york",
        "editing",
        "g",
        "crosse"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}